{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "P.1 lineage",
      "SARS-CoV-2",
      "gamma",
      "genomic surveillance"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35171035",
  "DateCompleted": {
    "Year": "2022",
    "Month": "03",
    "Day": "04"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "04"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "02",
        "Day": "16"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e01511-21",
      "10.1128/spectrum.01511-21"
    ],
    "Journal": {
      "ISSN": "2165-0497",
      "JournalIssue": {
        "Volume": "10",
        "Issue": "1",
        "PubDate": {
          "Year": "2022",
          "Month": "Feb",
          "Day": "23"
        }
      },
      "Title": "Microbiology spectrum",
      "ISOAbbreviation": "Microbiol Spectr"
    },
    "ArticleTitle": "Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.",
    "Pagination": {
      "StartPage": "e0151121",
      "MedlinePgn": "e0151121"
    },
    "Abstract": {
      "AbstractText": [
        "The SARS-CoV-2 P.1 lineage emerged in Amazonas (AM), North Brazil and its evolution has been dynamically reported associated with increased transmissibility and/or immune evasion. Here, we evaluated the lineages circulating in 29 cities in Rio Grande do Sul (RS), Southern Brazil between March 2020 and May 2021 and investigated the genetic events associated with the emergence of the P.1. A total of 202 oro/nasopharyngeal SARS-CoV-2 specimens from patients during routine hospital care were submitted to whole-genome sequencing. Phylogenetic and Bayesian Evolutionary Analyses of the P.1 lineage were carried out to determine the relationship between sequences from RS and AM and dated their common ancestor and origin. One hundred six (53%) sequences were assigned as P.1 and most carried the 22 lineage-defining mutations. All the P.1 sequences included other important mutations, such as P314L and R203K/G204R, and revealed a high genetic diversity in the phylogenetic tree. The time-scaled inference suggests that the oldest P.1 sequences from different Brazilian states share a ancestor with those from AM, but the origin of some sequences from RS is unknown. Further, the common ancestor of sequences from RS is dated to mid-June/July 2020, earlier than those previously reported from AM. Our results demonstrate that there is a high degree of genetic diversity among P.1 sequences, which suggests a continuous evolution and community spread of the virus. Although the first P.1 outbreak was reported in AM, the lineage was associated with multiple introductory events and had already been circulating in Southern Brazil prior to November 2020. <b>IMPORTANCE</b> The SARS-CoV-2 P.1 lineage is associated with increased transmissibility and/or immune evasion and presents a dynamic evolution in Brazil. The significance of our research relies in the fact that we evaluated the SARS-CoV-2 lineages circulating in Southern Brazil between March 2020 and May 2021. This evaluation allowed us to detect the genetic events associated with the emergence of the P.1 and its sublineages. This study is important because we were able to establish that the common ancestor of P.1 sequences from Rio Grande do Sul, Southern Brazil, is dated of mid-June/July 2020, earlier than the P.1 sequences previously reported from Amazonas (AM) state. Noteworthy, the high degree of genetic diversity among P.1 sequences found in this study suggests a continuous evolution and community spread of the virus. Moreover, the oldest P.1 sequences from different Brazilian states share a ancestor with those from AM."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-8126-2365"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "LABRESIS-Laborat\u00f3rio de Pesquisa em Resist\u00eancia Bacteriana, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Diagn\u00f3stico de SARS-CoV-2, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil."
          }
        ],
        "LastName": "Wink",
        "ForeName": "Priscila Lamb",
        "Initials": "PL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Bioinformatics Core, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          }
        ],
        "LastName": "Ramalho",
        "ForeName": "Rafaela",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "LABRESIS-Laborat\u00f3rio de Pesquisa em Resist\u00eancia Bacteriana, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Diagn\u00f3stico de SARS-CoV-2, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Diagn\u00f3stico Molecular, Universidade Franciscana, Santa Maria, Rio Grande do Sul, Brazil."
          }
        ],
        "LastName": "Monteiro",
        "ForeName": "Francielle Liz",
        "Initials": "FL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "LABRESIS-Laborat\u00f3rio de Pesquisa em Resist\u00eancia Bacteriana, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Diagn\u00f3stico de SARS-CoV-2, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias M\u00e9dicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil."
          }
        ],
        "LastName": "Volpato",
        "ForeName": "Fabiana Caroline Zempulski",
        "Initials": "FCZ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "LABRESIS-Laborat\u00f3rio de Pesquisa em Resist\u00eancia Bacteriana, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Diagn\u00f3stico de SARS-CoV-2, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          }
        ],
        "LastName": "Willig",
        "ForeName": "Julia Biz",
        "Initials": "JB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "LABRESIS-Laborat\u00f3rio de Pesquisa em Resist\u00eancia Bacteriana, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Bioinformatics Core, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          }
        ],
        "LastName": "Lovison",
        "ForeName": "Ot\u00e1vio von Ameln",
        "Initials": "OVA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "LABRESIS-Laborat\u00f3rio de Pesquisa em Resist\u00eancia Bacteriana, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias M\u00e9dicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Infectious Diseases Service, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          }
        ],
        "LastName": "Zavascki",
        "ForeName": "Alexandre Prehn",
        "Initials": "AP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "LABRESIS-Laborat\u00f3rio de Pesquisa em Resist\u00eancia Bacteriana, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Laborat\u00f3rio de Diagn\u00f3stico de SARS-CoV-2, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias M\u00e9dicas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil."
          }
        ],
        "LastName": "Barth",
        "ForeName": "Afonso Lu\u00eds",
        "Initials": "AL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "LABRESIS-Laborat\u00f3rio de Pesquisa em Resist\u00eancia Bacteriana, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Bioinformatics Core, Hospital de Cl\u00ednicas de Porto Alegregrid.414449.8, Porto Alegre, Rio Grande do Sul, Brazil."
          },
          {
            "Identifier": [],
            "Affiliation": "Departamento de Microbiologia, Imunologia e Parasitologia, Instituto de Ci\u00eancias B\u00e1sicas, Universidade Federal do Rio Grande do Sul, Rio Grande do Sul, Brazil."
          }
        ],
        "LastName": "Martins",
        "ForeName": "Andreza Francisco",
        "Initials": "AF"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Microbiol Spectr",
    "NlmUniqueID": "101634614",
    "ISSNLinking": "2165-0497"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Spike Glycoprotein, Coronavirus"
    }
  ],
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Brazil"
    },
    {
      "QualifierName": [
        "epidemiology",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genome, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genomics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Phylogeny"
    },
    {
      "QualifierName": [
        "classification",
        "genetics",
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Spike Glycoprotein, Coronavirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Whole Genome Sequencing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ],
  "CoiStatement": "The authors declare a conflict of interest. A.P.Z., A.L.B. and A.F.M. are research fellows of the National Council for Scientific and Technological Development (CNPq), Ministry of Science and Technology, Brazil. A.P.Z. has received a research grant from Pfizer not related to this work. All other authors declare no conflict of interest."
}